Allergy News and Research

RSS

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.

Low vitamin D in children linked to higher atopic dermatitis risk, study finds

Study reveals that low vitamin D levels in early childhood are linked to increased allergen sensitization and a higher risk of developing atopic dermatitis.

2 Apr 2024

Four years after shelter-in-place, covid-19 misinformation persists

From spring break parties to Mardi Gras, many people remember the last major “normal” thing they did before the novel coronavirus pandemic dawned, forcing governments worldwide to issue stay-at-home advisories and shutdowns.

1 Apr 2024

Skin tape sampling reveals early signs of food allergies in newborns

Food allergies occur often in childhood and can be severe or even fatal. Researchers at National Jewish Health are working to develop a program to prevent food allergies and have now identified early predictors of the condition.

29 Mar 2024

Antibody discovery could explain mysteries about COVID-19 and long COVID

UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID.

28 Mar 2024

Assistance dogs may detect PTSD flashbacks via breath

Dogs' sensitive noses can detect the early warning signs of many potentially dangerous medical situations, like an impending seizure or sudden hypoglycemia.

28 Mar 2024

Food allergies' broad impact on quality of life demands greater awareness

Review article in Frontiers in Nutrition examines the multifaceted impacts of food allergies on individuals' economic, psychological, and social quality of life, highlighting the need for increased awareness and support for affected people.

28 Mar 2024

Breakthrough study offers hope for an effective HIV cure

By 2030, the World Health Organization (WHO), the Global Fund and UNAIDS are hoping to end the human immunodeficiency virus (HIV) and AIDS epidemic.

26 Mar 2024

UVA researchers develop online tool to combat childhood diarrheal diseases

University of Virginia researchers are developing a flexible online tool for navigating information used in the fight to save children from deadly diarrheal diseases by identifying transmission hotspots and accelerating the deployment of treatments and new vaccines.

25 Mar 2024

Innovative study on asthma inflammation funded by NIH/NIAID grant

In a significant stride for respiratory medicine, Lundquist Institute (TLI) investigator Nicholas Jendzjowsky, PhD, has been awarded a prestigious grant from the National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID).

21 Mar 2024

Immune cell protein identified as potential target for rare liver cancer treatment

Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease is caused by a single genetic mutation that creates a fusion protein.

20 Mar 2024

Needle pain is a big problem for kids. One California doctor has a plan.

Almost all new parents go through it: the distress of hearing their child scream at the doctor's office.

20 Mar 2024

Milk ladder approach offers hope for children with cow's milk allergy

Researchers review milk ladder use for managing cow's milk allergy in children, emphasizing its potential in safely introducing cow's milk to induce tolerance and the need for standardization and further research.

19 Mar 2024

New drug candidates show promise to reverse HIV immune evasion

University of Pittsburgh School of Medicine scientists have identified drug candidates that show promise to reverse the ability of HIV to escape detection by the immune system.

19 Mar 2024

Study uncovers how APOBEC enzymes drive cancer mutations

A research team led by the University of California, Irvine has discovered the key role that the APOBEC3A and APOBEC3B enzymes play in driving cancer mutations by modifying the DNA in tumor genomes, offering potential new targets for intervention strategies.

18 Mar 2024

Study shows the economic benefits of reducing socioeconomic disparities in youth physical activity

What would happen if the existing disparities in physical activity levels between youth of lower and higher socioeconomic statuses were eliminated?

15 Mar 2024

Researchers find link between gut bacteria and the success of milk-allergy oral immunotherapy

Researchers led by Hiroshi Ohno at the RIKEN Center for Integrative Medical Sciences in Japan have discovered a link between gut bacteria and the success of milk-allergy oral immunotherapy.

14 Mar 2024

AI technologies can accurately identify cases of healthcare-associated infections

A new proof-of-concept study published today in the American Journal of Infection Control (AJIC) reports that artificial intelligence (AI) technologies can accurately identify cases of healthcare-associated infections (HAI) even in complex clinical scenarios.

14 Mar 2024

World Vaccine Congress draws leaders from government, science and industry

Sessions cover topics from cancer vaccines to logistics and the next.

From World Vaccine Congress Washington 13 Mar 2024

NIH study uncovers vulnerable sites on Epstein-Barr virus protein

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.

12 Mar 2024

Vaginal ring and oral PrEP found to be safe for HIV prevention among pregnant cisgender women

The monthly dapivirine vaginal ring and daily oral pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine were each found to be safe for HIV prevention among cisgender women who started using one of them in their second trimester of pregnancy, according to findings presented today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.

5 Mar 2024